Session # C-84

Multi-gene Panel Testing for Prostate Cancer: What Have We Learned So Far?

  • Hereditary prostate cancer testing is underutilized especially when compared to hereditary breast cancer testing
  • HOXB13 was a new finding, identified in 17% of positive patients
  • 13% of positive patients did not meet NCCN genetic testing guidelines for BRCA1/2

Search Results

Start your search...